Letters to the editor: Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer-Reference-Cited by-同舟云学术

Letters to the editor: Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer

Published:1993-11 Issue:9 Volume:4 Page:793-794
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kattan J.,Culine S.,Théodore C.,Droz J.-P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/4/9/793/408496/4-9-793.pdf

Reference5 articles.

1. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium;Sternberg;Efficacy and patterns of response and relapse. Cancer,1989

2. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder;Boutan-Laroze;Eur J Cancer,1991

3. Second-line cisplatin (C) treatment (RX) in patients with ovarian cancer (OC) previously treated with cisplatin (Abstract);Markman;Proc Am Soc Clin Oncol,1990

4. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy;Geller;Cancer,1991

5. Escalated therapy for refractory urothelial tumors: Methotrexate-vinblastine-doxurubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor;Logothetis;J Ntl Cancer Inst,1990

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma;Canadian Urological Association Journal;2019-04-25

2. The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG);Targeted Oncology;2019-01-29

3. SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer;World Journal of Urology;2018-09-20

4. A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer;Immunotherapy;2018-06

5. Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer;OncoTargets and Therapy;2017-03